Leucine enkephalin degradation in allergopathic versus normal human plasma. 1998

L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
Dipartimento di Medicina Sperimentale, Università degli Studi di Roma Tor Vergata, Rome, Italy.

The enzyme hydrolysis of labelled leu-enkephalin in the presence of plasma enzymes was studied by kinetic and chromatographic techniques in a group of allergopathic patients in the acute and quiescent stage; data obtained have been compared with those obtained with normal controls. Results shown indicate that in the quiescent stage substrate degradation is reduced, and that the pattern of the hydrolysis by-products is modified with respect to the controls. In the acute as compared to the quiescent stage, enkephalin hydrolysis is further reduced, and the pattern of hydrolysis by-products is further modified. ANOVA analysis of these data indicates that the dependency of hydrolysis reduction upon the grouping of subjects (i.e., controls, quiescent and acute stage) is statistically very significant. Reduced substrate hydrolysis, and modified hydrolysis pattern, appears to be associated with decreased activity of the enzymes involved and more significantly with increased activity of the low molecular weight plasma inhibitors. The combination of these two factors appears to define a hydrolysis pattern characteristic of the allergopathic subjects, similar in the quiescent and acute phase, and different from that observed in the controls.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004743 Enkephalin, Leucine One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN. Leucine Enkephalin,5-Leucine Enkephalin,Leu(5)-Enkephalin,Leu-Enkephalin,5 Leucine Enkephalin,Enkephalin, 5-Leucine,Leu Enkephalin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.

Related Publications

L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
January 1998, Peptides,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
October 1983, The Journal of clinical endocrinology and metabolism,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
February 1999, The Journal of pharmacology and experimental therapeutics,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
January 1999, Gerontology,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
February 1981, The Journal of clinical endocrinology and metabolism,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
October 1989, Gut,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
March 1982, The Journal of clinical investigation,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
October 2018, Analytical biochemistry,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
January 1988, General pharmacology,
L Bongiorno, and L Fuso, and M Marini, and M Marzano, and B Nardecchia, and L G Roda, and P Rossi, and A Urbani
January 1986, NIDA research monograph,
Copied contents to your clipboard!